Ghana's pharmaceutical market is among the largest in the West African region yet remains small on a global scale. Ghana's pharmaceutical market was valued at GHS1.29bn (USD293mn) in 2017, which is fairly modest in global terms and even by regional standards, representing just under USD11 per capita. Prescription medicines dominate the market representing 73% by value, while OTC medicines occupy a considerably smaller share at 27%. The prescription market share is split relatively evenly between patented drugs and generic drugs. However, we expect the market to become increasingly penetrated by generic medicines over the long-term, somewhat eroding patented medicines' share. Pharmaceutical sales accounted for 0.5% of GDP and 13% of total healthcare expenditure in 2017.

Key View

SWOT

Industry Forecast

Industry Risk/Reward Index

Regulatory Development

Market Overview

Competitive Landscape

Company Profile

Ghana Demographic Outlook 

Pharmaceuticals & Healthcare Glossary 

Pharmaceuticals & Healthcare Methodology